BRIEF published on 08/04/2025 at 14:05, 4 months 18 days ago Medincell Annonce son Assemblée Générale 2025 Gouvernance Assemblée Générale Resolutions Medincell Rémunérations
BRIEF published on 08/04/2025 at 14:05, 4 months 18 days ago Medincell Announces its 2025 General Meeting Governance General Meeting Resolutions Remuneration Medincell
PRESS RELEASE published on 08/04/2025 at 14:00, 4 months 18 days ago Informations privilégiées / Autres communiqués Medincell publie la convocation pour son assemblée générale annuelle mixte 2025, incluant des résolutions sur les comptes, l'approbation des dirigeants et des délégations au Conseil d'administration Assemblée Générale Convocation Resolutions Pharmaceutique Medincell
BRIEF published on 07/30/2025 at 14:34, 4 months 23 days ago Chiffre d'affaires croissant de Medincell et prochaines soumissions Traitement De La Schizophrénie Chiffre D'affaires De Medincell Ventes UZEDY Soumission D'olanzapine Partenariat Teva
BRIEF published on 07/30/2025 at 14:34, 4 months 23 days ago Medincell's Rising Revenue and Upcoming Submissions Schizophrenia Treatment Teva Partnership Medincell Revenue UZEDY Sales Olanzapine Submission
PRESS RELEASE published on 07/30/2025 at 14:32, 4 months 23 days ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Medincell accélère avec des prévisions de ventes 2025 relevées pour UZEDY® et confirmation de la demande de mise sur le marché américain pour l'Olanzapine LAI Schizophrénie Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
PRESS RELEASE published on 07/30/2025 at 14:29, 4 months 23 days ago INSIDE INFORMATION / OTHER NEWS RELEASES Medincell's partner Teva Pharmaceuticals raises 2025 revenue outlook for UZEDY® to $190–$200M and confirms Olanzapine LAI on track for submission in 2025 Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI Submission
BRIEF published on 07/30/2025 at 13:47, 4 months 23 days ago Les prévisions de résultats financiers prometteurs pour les médicaments UZEDY® et Olanzapine LAI de Medincell Traitement De La Schizophrénie Teva Pharmaceuticals Prévisions De Revenus De Medincell Performances UZEDY® Développement De L'olanzapine LAI
BRIEF published on 07/30/2025 at 13:47, 4 months 23 days ago Medincell's UZEDY® and Olanzapine LAI Forecast Promising Financial Outcomes Schizophrenia Treatment Teva Pharmaceuticals Medincell Revenue Forecast UZEDY® Performance Olanzapine LAI Development
PRESS RELEASE published on 07/30/2025 at 13:42, 4 months 23 days ago Inside Information / Other news releases Medincell's partner Teva increases 2025 revenue outlook for UZEDY® to $190–$200M, plans olanzapine LAI submission. Company's innovative treatments aim to improve medicine accessibility Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
Published on 12/22/2025 at 15:00, 4 hours 51 minutes ago World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Published on 12/22/2025 at 14:40, 5 hours 11 minutes ago Namibia Critical Metals Inc. Receives Proceeds of $1,154,762 from Exercise of Warrants
Published on 12/22/2025 at 14:30, 5 hours 21 minutes ago Prospect Ridge Updates Diamond Drill Program at 100% Owned Camelot Copper-Gold Project in B.C.'S Cariboo Mining District
Published on 12/22/2025 at 14:00, 5 hours 51 minutes ago Rio Grande Resources Completes 2025 Field Program and Advances Drill Targeting at the Winston Gold-Silver Project
Published on 12/22/2025 at 14:00, 5 hours 51 minutes ago PPX Mining Appoints Ernest Mast as President and CEO and Announces Stock Option Grants
Published on 12/22/2025 at 19:31, 20 minutes ago EQS-Adhoc: Marley Spoon Group SE: CEO Daniel Raab Re-appointed and Contract to be Extended until June 2029
Published on 12/22/2025 at 19:00, 51 minutes ago PATRIMOINE ET COMMERCE: Déclarations des transactions sur actions propres (hors contrat de liquidité) réalisées le 19 décembre 2025
Published on 12/22/2025 at 18:51, 59 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/22/2025 at 18:20, 1 hour 30 minutes ago CGTN: How China drives high-quality development through technological innovation
Published on 12/22/2025 at 18:14, 1 hour 36 minutes ago Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
Published on 12/22/2025 at 18:33, 1 hour 18 minutes ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 1 hour 46 minutes ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 1 hour 46 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 2 hours 6 minutes ago Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 2 hours 16 minutes ago DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025
